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Class II (Ia) major histocompatibility complex molecules are cell surface proteins normally expressed by a
limited subset of cells of the immune system. These molecules regulate the activation of T cells and are required
for the presentation of antigens and the initiation of immune responses. The expression of Ia in B cells is
determined by both the developmental stage of the B cell and by certain external stimuli. It has been
demonstrated previously that treatment of B cells with lipopolysaccharide (LPS) results in increased surface
expression of Ia protein. However, we have confirmed that LPS treatment results in a significant decrease in
mRNA encoding the Ia proteins which persists for at least 18 h. Within the upstream regulatory region of A'k,
an NF-KB-like binding site is present. We have identified an LPS-induced DNA-binding protein in extracts
from athymic mice whose spleens consist predominantly of B cells. Binding activity is present in low levels in
unstimulated spleen cells and is increased by LPS treatment. This protein binds to two sites in a regulatory
region of the Ia A.k gene, one of which contains the NF-KB-like binding site. DNA fragments containing these
sites cross-compete for protein binding. Analysis by DNase I footprinting identified a target binding sequence,
named the LPS-responsive element. Although this target sequence contains an NF-KB-like binding site,
competition with a mutant oligonucleotide demonstrated that bases critical for NF-KB binding are not required
for binding of the LPS-inducible protein. Therefore, we hypothesize that this inducible protein represents a
new mediator of LPS action, distinct from NF-KB, and may be one mechanism to account for the decrease in
mRNA encoding the Ia proteins.
The class II (Ia) molecules are a family of cell surface
glycoproteins encoded in the I subregion of the major
histocompatibility complex (15) on murine chromosome 17.
This subregion encodes four class II genes, Aot, AP, Eox, and
E3, which are coexpressed. The cell surface proteins, I-A
and I-E, are the products of noncovalent pairing of the (x and
P subunits. These proteins play a critical role in antigen
presentation and immune-cell interactions (36). Increased
levels of cell surface Ia on B cells increase the ability of these
cells to present antigens to T lymphocytes (20). Expression
of I-subregion proteins (Ia) and immunoglobulins in B cells is
developmentally regulated. As B cells mature from pre-B to
mature B cells, immunoglobulin synthesis is initiated and
cells express specific immunoglobulin. These cells may
differentiate further into antibody-producing plasma cells. Ia
antigen is expressed as pre-B cells differentiate, persists in
mature B cells, and is lost upon terminal differentiation to
antibody-secreting plasma cells (18, 31). In addition, exter-
nal stimuli, such as interleukin-4 (IL-4) (26) and antibodies to
B-cell-differentiation antigens including surface immuno-
globulin M (22) and immunoglobulin D (17), increase the
level of expression of class II antigens on B cells. Although
a number of stimuli have been shown to increase the
expression of B-cell surface Ia, few signals have been shown
to decrease its expression. Recently, however, corticoste-
roids were shown to reduce the expression of surface Ia on
resting and activated murine B cells (21).
Lipopolysaccharide (LPS) is an integral component of the
outer membrane of gram-negative bacteria and is a powerful
B-cell mitogen. Approximately 30% of murine B cells re-
spond to LPS by becoming blasts and secreting immunoglob-
ulin (24). This program of immunoglobulin gene activation
* Corresponding author.
may be mediated in part by the protein NF-KB, which is
involved in transcription of the K-chain gene. The nuclear
localization and binding of NF-KB to a transcriptional motif
within the K light chain enhancer are induced by LPS in
pre-B cells (4, 37, 38). Previous data from our laboratory
obtained by using a panel of transformed pre-B cell lines
suggested that class II major histocompatibility complex and
immunoglobulin gene expression may be controlled by dis-
tinct pathways in early B cells (30). We therefore undertook
the study of the effects of LPS on one of the class II major
histocompatibility complex genes, Aot. Some information on
the effect of LPS treatment on class II expression in B cells
is available. Studies of the surface expression of Ia antigens
in B cells after treatment with LPS has shown an apparent
increase in surface expression which has been most convinc-
ingly documented at 36 to 64 h after treatment (9, 23, 41).
However, it has also been demonstrated that LPS treatment
leads to an early and significant decrease in levels of mRNA
for Au and AP in murine spleen cells by 12 h (33).
The molecular mechanisms responsible for these effects
are unknown. To study the early effects of LPS on class II
gene expression and to compare these with the effects of
LPS on immunoglobulin expression, the upstream region of
the class II Ao. gene was examined. This 1.25-kilobase (kb)
region has previously been shown by us to be active in Cis in
murine B cells in a tissue-specific manner (5). Highly con-
served transcriptional motifs called X and Y are present
upstream of all class II genes sequenced to date. The
conserved region containing these elements is found within
bases -50 to -150 relative to the AUG initiator codon. The
X motif is conserved and lies 19 to 21 base pairs (bp)
upstream from the Y motif. Studies with transgenic mice (11)
have shown that the X and Y motifs are essential c is-acting
elements for the transcription of class II genes. They are
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LPS-INDUCED DNA-BINDING PROTEIN FOR A CLASS II GENE 3185
required for the accurate initiation of transcription in vivo
and bind sequence-specific proteins. However, these se-
quences alone cannot account for the cis-activating effect of
the 1.25-kb Aot upstream region (5, 6).
In this report, we demonstrate the presence of an LPS-
inducible DNA-binding protein in nuclear extracts prepared
from athymic (nulnu) mouse splenocytes which binds to Aot
sequences upstream of the X and Y motifs. Northern (RNA)
blot analysis of splenic RNA confirmed previous dot blot
analyses that LPS exposure results in a rapid reduction in
Aa mRNA which persists throughout the 18 h culture
period. Within the culture period, there was increased
binding of the LPS-inducible protein to two sites in the
upstream regulatory region of the Aot gene. Binding to each
site was specifically inhibited by each of the two DNA
fragments containing these sequences. A target sequence for
binding was determined by DNase I footprint analysis, and
an oligonucleotide corresponding to this region prevented
binding. Although an NF-KB-like binding site is present
within this target sequence, we have demonstrated that this
site is not necessary for binding and that the true NF-KB
target sequence does not inhibit binding. Thus, the LPS-
inducible protein which binds to the regulatory region of the
class II Aot gene is not NF-KB.
MATERIALS AND METHODS
Cells and culture. Outbred ni/lnl mice, 4 to 6 weeks old
(obtained from R. Sedlacek, Massachusetts General Hospi-
tal, Boston), were killed by CO2 asphyxiation. Spleens were
harvested sterilely and crushed in complete media consisting
of RPMI 1640 supplemented with 5% heat-inactivated fetal
bovine serum (catalog no. A-1111-L, lot no. 1111815; Hy-
clone Laboratories Inc.), 10 mM HEPES (N-2-hydroxyeth-
ylpiperazine-N'-2-ethanesulfonic acid; Whittaker M. A. Bio-
products), 2 mM glutamine, 0.1 mM 2-mercaptoethanol, and
100 U of penicillin per ml and 100 ,ug of streptomycin per ml
(both from GIBCO Diagnostics). Hyclone serum and
HEPES used in the complete media have negligible levels of
LPS by assay. Media were tested by Chris Lu, Department
of Medicine, Brigham and Women's Hospital, Boston,
Mass., via the Limulus lysate assay (Cape Cod LEL Endo-
toxin Kit; Cape Cod Associates) and found to contain <0.32
ng of LPS per ml. Erythrocytes were lysed, and cells were
washed with complete media, centrifuged, and suspended in
complete media at a density of 2.5 x 106/ml. For LPS
stimulation, cell preparations were divided in half and cul-
tured overnight in media alone or in media containing
Escherichia coli LPS (Sigma Chemical Co.) to a final con-
centration of 50 ,ug/ml. Cells were harvested for nuclear
extract preparation after 18 h of overnight culture. Fluores-
cence-activated cell sorter analysis was performed on cells
first incubated with a rat anti-Ia monoclonal antibody, M5/
114 (14), followed by incubation with a fluorescein-conju-
gated goat anti-rat immunoglobulin G reagent to assess
stimulation of surface Ta with a FACS analyzer (Becton
Dickinson and Co.) as previously described (31). The M5/114
monoclonal antibody detects polymorphic determinants on
spleen cells from mice of H-2 haplotypes b, d, q, and k.
Nuclear extracts. Cells were harvested and washed in
phosphate-buffered saline. Nuclear extracts (10) were pre-
pared using 2 x 108 to 8 x 108 cells by a modification of the
method of Dignam et al. as described elsewhere (6), except
that the final salt concentration was adjusted to 0.5 M to
allow for lysis for 45 min, centrifugation was at 150,000 x g
for 30 min, and 3 to 4 volumes of buffer C (20 mM HEPES
[pH 7.9], 0.42 M NaCl, 1.5 mM MgCl,2 0.2 mM EDTA, 0.5
mM phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol,
25% glycerol [vol/vol]) per estimated cell volume was used.
DNA fragment and probe preparation. DNA fragments
were prepared from a BglII-SacI upstream fragment of the
I-A k gene extending 1.9 kb upstream of exon I and cloned
in the BamHI and SacI sites of pUC18. The techniques used
for fragment preparation, restriction digests, and gel sizing
and separation were as described elsewhere (6). Probe DNA
was 5'-end labeled after treatment with calf alkaline phos-
phatase by T4 polynucleotide kinase in the presence of
[y-32P]ATP (3,000 to 6,000 Ci/mmol; Dupont, NEN Re-
search Products). 3'-End labeling was performed with the
Klenow fragment of DNA polymerase I in the presence of
[ax-32P]ATP (3,000 Ci/mmol; NEN) under standard condi-
tions. Labeled DNA was extracted sequentially with phenol-
chloroform (1:1) and chloroform and separated on 5% poly-
acrylamide gels in 1x Tris-borate-EDTA. Unlabeled DNA
fragments were used in competition experiments.
Oligonucleotides were synthesized on a synthesizer (Bio-
search) by standard phosphoramidite techniques. Overnight
deprotection for 8 to 12 h was accomplished with fresh
ammonium hydroxide at 55°C. After being vacuum dried and
washed in sterile distilled water, 100 ,ug of single-stranded
DNA was loaded on an 8 M urea denaturing gel (12%
polyacrylamide). DNA bands were visualized by UV shad-
owing, cut and eluted overnight in 0.5 M NaCl-10 mM
MgCl2-10 mM Tris hydrochloride (pH 7.6), and ethanol
precipitated. Complementary strands were annealed in 0.6
M NaCl-20 mM Tris hydrochloride (pH 7.6)-i mM EDTA
by heating them to 95°C for 5 min, placing them in 65°C for
5 min, and cooling them to room temperature over 3 to 4 h.
Annealed oligonucleotides were ethanol precipitated in the
presence of 10 mM MgCl,. For Northern blot hybridization,
probes were an agarose gel-purified cDNA fragment of 1.0
kb for Ax and a 1.1-kb fragment of A50 cDNA (25). These
probes were labeled by nick translation (34) with [oL-32P]
dCTP (3,000 Ci/mmol; NEN).
DNA-binding (mobility shift) assays. DNA-binding assays
were performed as described elsewhere (6). Nuclear extracts
were incubated with equal volumes of sterile water or
competitor DNA at room temperature for 5 min. The remain-
der of the reaction components, including labeled fragments,
were then added, with optimal poly(dI-dC) (dI-dC) concen-
tration being 0.33 mg/ml in a 12-,ul reaction, and incubated
for 20 min. Samples were run on 4% polyacrylamide gel
electrophoresis in 45 mM Tris-borate-1 mM EDTA at 200 V
with cooling. Gels were then dried under vacuum, and
autoradiography was performed. Nuclear extracts were nor-
malized for protein concentration, and equal amounts of
protein, usually 0.5 to 1.5 pLg, were added within experi-
ments.
DNase I footprint analysis. DNA-binding reactions were
performed as described above but were proportionally
scaled up to a 25- to 30-1l volume in each of five lanes.
Optimal DNase I concentration was determined by concen-
tration curves and was found to be 2 ,ug/ml for the fragment
II probes. Fragments were labeled at the 3' and 5' ends in
separate experiments, and 500,000 Cerenkov cpm was used
per total reaction. After standard incubation to allow bind-
ing, 3 ,ul of 50 mM MgCl2-50 mM CaCl2 was added, with the
subsequent addition of 37°C-activated DNase I. Samples
were incubated for 90 s at room temperature, quenched with
EDTA and EGTA [ethylene glycol-bis(,-aminoethyl ether)-
N,N,N',N'-tetraacetic acid] to 5 mM each and subjected to
4% polyacrylamide gel electrophoresis in 45 mM Tris-bo-
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FIG. 1. FACS analysis of whole-spleen preparations from athy-
mic mice with and without exposure to LPS at 50 ,ug/ml. Control
antibody is fluorescein-conjugated goat anti-rat immunoglobulin G.
Anti-Ia antibody was M5/114, a monoclonal rat anti-Ia antibody (14).
Cell surface staining was performed after 18 h of culture. Experi-
ment 1 shows no induction of surface Ia with LPS exposure, as was
seen in two of seven experiments. Experiment 2 shows a modest
induction of surface Ia, as was seen in five of seven experiments.
rate-1 mM EDTA. Free and bound bands, identified by
autoradiography of wet gels, were cut from the gels and
eluted by diffusion. DNA was purified on Elutips columns
(Schleicher & Schuell) and ethanol precipitated. Products of
DNase I digestion were resolved on 6% polyacrylamide-8 M
urea linear and wedge sequencing gels. An equal number of
radioactive counts were loaded in each free and bound lane.
Maxam-Gilbert ladders of unreacted probe were run simul-
taneously in order to identify sequences (13).
RNA analysis. In timed experiments, all cultures were
maintained for a total of 18 h, regardless of treatment. Total
cellular RNA was harvested from nulnui mouse spleen cells
by the guanidine isothiocyanate-cesium chloride density
gradient method of Chirgwin et al. (8). Agarose gels (1.3%)
containing 0.22 M formaldehyde were used for size fraction-
ations. RNA was transferred in 20x SSC (1x SSC is 0.15 M
NaCl plus 0.015 M sodium citrate) to Nytran filters as
described elsewhere (8). Northern blots were prehybridized
for 2 h at 42°C in 48% formamide-5 x SSC-10 mM Tris-0.1%
sodium dodecyl sulfate-i x Denhardt solution-10% dextran
sulfate-100 ,ug of denatured sheared herring sperm DNA per
ml. Hybridization was for 36 h under identical conditions
with the addition of 100 ,ug of herring sperm DNA and 1 x
106 to 3 x 106 cpm of nick-translated cDNA probe per ml of
final volume. Duplicate filters were hybridized to either Aox
probe or A50 probe. Filters were washed twice for 30 min
each in 2x SSC-0.1% sodium dodecyl sulfate at room
temperature and then twice for 30 min each at 65°C in 0.2x
SSC-0.1% sodium dodecyl sulfate. Autoradiography was
performed on wet filters. Filters were then washed under
conditions to remove bound probe and rehybridized to the
second probe.
RESULTS
LPS treatment minimally affects surface Ia expression and
decreases level of Ta mRNA at early time points. Figure 1
shows representative results of FACS analysis experiments
on expression of surface Ia antigens in whole-spleen prepa-
rations from athymic mice with and without LPS exposure at
18 h. These mice are maintained through life in a germfree
FIG. 2. Northern blot analysis of the time course of LPS effect
on Aa mRNA. Total cellular RNA was harvested from splenic
lymphocytes of athymic mice after being cultured with 50 jig/ml of
LPS for 1 h (lanes 2 and 7), 4 h (lanes 3 and 8), 9 h (lanes 4 and 9),
and 18 h (lanes 5 and 10). Total culture time for all samples was 18
h. Unstimulated spleen cells cultured for 18 h (lanes 1 and 6) served
as control. Total RNA (10 ,ug per lane, as measured by optical
density at 260 nm) was used to prepare duplicate Northern blots
which were hybridized to either Aa probe or A50 probe. Rehybrid-
ization of the same filters with the second probe confirmed these
results.
environment and thus are protected at baseline from expo-
sure to endotoxin. In addition, athymic mice are T-cell
deficient, and splenic lymphocytes are thus predominantly B
cells. Flasks stimulated with LPS (50 ,ug/ml) were examined
microscopically after 18 h, and blast formation was present
in all experiments. Although other investigators have shown
an early two- to threefold increase in surface Ia antigen
expression after treatment with LPS (9), we have seen a very
modest increase in surface Ia expression at 18 h in five of
seven experiments and no increase in expression in two
experiments. One experiment from each group is shown.
Since the FACS data are not normalized for the increase in
cell surface area produced by LPS treatment, these data
suggest that at early time points of stimulation, LPS is not a
positive regulator of Ia expression.
Dot blot analysis of spleen cells treated with LPS (25
,ug/ml) for up to 12 h has suggested that such treatment leads
to a decrease in mRNA encoding Ia proteins (33). We
performed Northern blot analyses of total RNA from stim-
ulated and unstimulated spleen cells (Fig. 2). RNA was
prepared from cells incubated with LPS for 1, 4, 9, and 18 h.
Filters were probed with Aa cDNA and A50 cDNA probes.
A50 contains sequences for a constitutively expressed
mRNA (25) and serves as a control for sample concentra-
tion. Northern blot analysis demonstrated that treatment
with LPS reduces the level of mature Aot mRNA in compar-
ison with unstimulated controls. Decrease in mRNA began
by 1 h (Fig. 2, lane 2), continued at 4 h, and was maximal by
9 h. At 18 h, mRNA levels remained substantially reduced in
comparison with unstimulated controls. Densitometry dem-
onstrated a reduction in Aot mRNA from baseline to 52% of
baseline at 1 h, 23% of baseline at 4 h, 19% of baseline at 9
h, and 22% of baseline at 18 h. Levels of both mature Aot
mRNA and a larger presumed Aa precursor mRNA were
reduced. Hybridization of a duplicate filter and rehybridiza-
tion of the same filter to the A50 cDNA probe indicate that
A50 mRNA concentrations were comparable among samples
and did not bias the results. In addition, levels of A50 mRNA
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LPS-INDUCED DNA-BINDING PROTEIN FOR A CLASS 11 GENE 3187
have remained constant with LPS stimulation. We conclude
that the level of Aa mRNA decreased with LPS treatment.
An LPS-inducible DNA-binding protein binds to an Aa
upstream sequence containing an NF-KB-like binding site. To
begin to examine the mechanism of LPS effects on class II
gene expression, we sequenced 1.23 kb of DNA of the
upstream regulatory region of A,,k. Figure 3 shows this
sequence, with the sequencing strategy shown below. The X
and Y consensus motifs are noted just upstream of the ATG
start codon. A reverse CCAAT box motif is also demarcated
within the Y box region. Of note is the absence of a TATA
box, as has been described in the upstream regions of other
genes (7). A DNA-binding protein whose binding activity is
influenced both by IL-4 and by differentiation in B cells has
been described (5). The DNA sequences bound by this
protein, BRE-1 and BRE-2, are noted. Of interest is that just
upstream of BRE-2 is the sequence AAGGGAATTTTCC
(Fig. 3A), which has a 10/12 sequence homology to the
known binding site of NF-KB, an LPS-inducible DNA-
binding protein specific for the immunoglobulin K gene
enhancer and regulatory for K light chain transcription in B
cells (37, 38).
Since the control of gene transcription is usually mediated
by trans-acting transcriptional factors which bind to up-
stream regulatory elements, we assayed nuclear extracts
from unstimulated and LPS-stimulated splenic preparations
from athymic mice for binding to seven DNA fragments
prepared by Hinfl digestion of 1.9 kb from the upstream
regulatory region of A,,k (Fig. 4A). Equal portions of unstim-
ulated and stimulated extracts were added to each radiola-
beled Hinfl fragment and assayed for binding activity by
mobility shift assays (Fig. 4B). All fragments were assayed,
including fragment IV, which contains the X-Y consensus
sequence region. Binding to fragment IV occurs in both
unstimulated and stimulated extracts (Fig. 4B, lanes 11 and
12) and represents constitutive binding to the X box and Y
box motifs (6). This binding activity is equivalent in induced
and uninduced spleen cells and serves as a control for
protein concentration. Retarded bands representing DNA-
protein complexes were present in LPS-induced extracts
when restriction fragments I and II (Fig. 4B, lanes 3 and 6)
were assayed with splenic nuclear extract. Binding activity
was seen at low level in the uninduced extracts (Fig. 4B,
lanes 2 and 5) but was present in much greater amounts in
LPS-induced extracts. Treatment of extract with proteinase
K abolished the DNA-protein complex (results not shown).
These results demonstrate the presence of an LPS-inducible
DNA-binding protein which binds to two sites in the up-
stream regulatory region of A,k.
To demonstrate specificity of protein binding to these Aa,k
regions, unlabeled competitor fragments were prepared from
cloned, truncated subfragments of fragments I and II: I(t)
and 11(t) (Fig. 4A) (5). Mobility shift assays were performed
after a 5-min preincubation with excess unlabeled competi-
tor DNA (Fig. 5). Unlabeled fragment I(t) prevented the
formation of a retarded complex when incubated with nu-
clear extract and radiolabeled fragment I (Fig. 5, lanes 3 and
11). Unlabeled unrelated competitor fragments did not pre-
vent binding (Fig. 5, lanes 5 and 13), demonstrating that the
protein binding is specific for fragment I. Unlabeled II(t) also
prevented protein binding to radiolabeled fragment II (Fig. 5,
lanes 8 and 16), but unrelated competitor DNA fragments did
not (lanes 9 and 17). In addition, cross-competition occurred
when unlabeled II(t) was used as a competitor for binding to
fragment I (Fig. 5, lane 12) and when 1(t) was used as
competitor for binding to fragment II (lane 15). Because
A 1 0 20 30 40 LRE 50 60 70
CTATAMCCTA MAAClt.M9AACTGTCT ATTACTATCATAAAATFATCTC1TACTA
GATATTGGT ITGTGAG1M 1G;AGTG TMATGATTAA i I M A#ATMA G*TG1T
80 90 100 110 BRE-2120 130 140
A;IWC 0AGY4AC iCOQG#TrA CCTMTATG lTG=TG A M3iX
TACCCAG CICiC its04CTAT WAATrTAC AAAOCTir II
150 160 170 160 190 200 210
AWATCrACT TTI iuiGTC OKYIS Clt@OC CISI: WCOW1G= TCC:CTGI
TOGTAGATG MTAYUYAB G1LG&W GRXXOYYG RY J G3GY>eA G3ACAAAT
220 230 240 250 260 270 280
GP3XAC TrGCACAC ATCrAG0 GOCAG3A CIGGCU# A1GTCG CcG1GR3rC
CIiuXXX AYXMTG1XG TAGA13C CiGTCi CTC C4CCGAITT TACAGGET OCS#C/CVG
290 300 310 320 330 340 350
1CC*AGAAT GCWAGCT CACTICTA TAYXAAO AAOCMAAT GG GMAG PTTAAGOT
AGTlCTTA OGC IITGA G1tAGk4G.T ATEI131T*CTCTfl3TG1A Cr#CGA1 TGATTrCA
Hinf1 Hinf1
,360 370 380 390 400 410 420
04*CTEXXA CbCTICTuG AAATGTTAGA "00A;gT ITCIATGA CCTAAATAT AhUATTIWA
GICTGI3T GTGAAAA.GC 1TrACMTCT Raul PA A8GATGGCT G7GATmTATA TMAATT
430 440 450 460 470 480 490
AAATATTTTA AGATACMG ACAOCAT A4CTG7G TGTGTcI GTiCAAAT IO.TCTfGA
1TrATAAAAT ITC kATTGC T1GkTGMTA TIG..Gqc ACKAGTC CGATTA AAM1CT
500 510 520 530 540 550 560
ATACAAAGT TGCT AAG GC31#AA ATCT0ATM AACICICTCA GI /G~TA
TATGT1TCTA OGTrrC CTCTYc:lT TTAACTAT lm3m TGAG3TOI CKAT
570 580 S90 600 610 620 630
GGITC.4CY GCTIG31T OCAACTGGTA ACTCCPr= TCGICAoAlV OC
Ct.OG1GT OYGA GSIAT ITGGIOCA 3 iCr O r ACiGgi iG
640 650 660 670
G A:A KAGA GCAAT G4CTiA
OCAmATGTlG TrrrCiCT OMTI AC GrA
710 720 730 740
TCATCTCACA ATTGAAO MA= ACTA33L
AGrGG13TAATMTAC XT GAGAOG1G TGATAOT
680 690 700
CeG1CrG1GG3kTACTrG GM33I1. 1.
GKIG#CO=C TA11DB/C CAlCCtACO
750 760 BRE-1 770
GMTAAAGA AMAA 1 AACrCATGAT
TTATTCT 1l1a TTGAGTACTA
780 790 800 810 820 830 840
G AAG0GAAAGT AAICTG3 CAAG3A a - GAGMTA II1
C7-Aa G 1TCTC;ITCA TTGA YCACGI 1 GINT c3rrC CrrAT TrAT
850 860 870 880 890 900 910
l1 CTCTAGT G A CGTrTATGAA GCAATATT AiTGiT1G AGCTTll
AGACTTGGITCA 03ICT GTCATACTT CIG1 TrATM TA 'C CAO4C
Hinf 1
920 930 940 950 960 970 980
TOCATG1TTA GMAATCOOC1T WCCICI iGC CATC1lTA CATAAGA AGTGGCrACA
=AC;rG CIlTp G 3 GTAG;AM GTI CGiG TCTCiCTCfi.GrC.ATC
990 1000 1010 1020 1030 1040 1050
AACCTTC ICAA C1CCI A TCCTTOA GTAGOO= CAG 1G AGTItEr
TlllGTGA A 31MC GKW# AGGlWC4a CA7lMGC GlDKWlA TCOCAA
1060 1070 1080 1090 1100 1110 1120
OCTAGTC1 TX:IC CTAATACAAA GIC ISGTAATGIG CGTATCC AAGAAAT
G AKGl0G;G GATTATGMTTLA TT
1130 1140 1150 1160 1170 1180 1190
TCIGATTCT1C1G1 T11TGiTGTGGGTCT CiTImIG A IWOC WCAAT CTCrAGAC
APMMZ AC.C A ACCAAG ACAOCTA¶GA GACT AGTGTTA GGAAT1TCM
1200 1210 1220 1230
; c c translation
IC~1TTOCG=TC 1t3iG CTGGTA
B E
0
I
xY
1230
4~~~~~~OE
FIG. 3. (A) Sequence of 1.23 kb of DNA of the upstream
regulatory region of A.k. Hinfl restriction sites are noted by vertical
bars. The target sequence of the LPS-induced DNA-binding protein
is designated by the cross-hatched bar. The target sequences of the
previously described (5) IL-4-responsive elements (BRE-1 and
BRE-2) are designated by open bars. The NF-KB-like sequence is
starred. X and Y boxes are indicated. Note that there is a reverse
CCAAT box motif located within the Y box, but there is no TATA
box in the upstream sequence. Numbering is arbitrarily designated
as 0 through 1230, since the actual site of initiation of transcription
has not been determined. (B) Sequencing strategy. Both strands
were sequenced by the Sanger dideoxy method with some overlap
from Maxam-Gilbert ladders. This sequence has been submitted to
GenBank and assigned accession number M24602.
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FIG. 4. (A) Schematic representation of the Hinfl restriction
digest of the upstream region of Aa. Hinfl sites are marked with
vertical hatches. Fragments are numbered according to size. Solid
boxes identify the conserved X and Y box consensus sequences
within fragment IV and the translation initiation of exon I leader
peptide to the right. I(t) and 11(t) denote the positions of cloned
truncated subfragments of fragments I and II. (B) Mobility shift
assays of unstimulated and LPS-stimulated extracts to fragments I
through VII. Unstimulated (-) and LPS-stimulated (+) extracts are
shown in pairs. Equal portions of extract were added to radiolabeled
Hinfl fragments from the upstream region of the A"k gene. Lanes 1,
4, 7, 10, 13, 16, and 19 contain no added nuclear extract. Retarded
bands are present when LPS-induced extracts are incubated with
fragments I and II (lanes 3 and 6) but not when they are incubated
with other fragments. Binding to fragment IV (lanes 11 and 12)
represents the constitutive X and Y box binding-protein activity
which is present in all splenic nuclear extracts and serves as a
control for protein concentration.
these cross-competition data implied that the same protein(s)
binds to fragments I and II, and because the closest match to
an NF-KB target sequence was present in the fragment II
DNA, we chose to focus on this fragment to identify the
region of protein binding.
A target sequence of the LPS-inducible binding protein is
identified. To determine the target sequence of the LPS-
induced binding protein, we performed DNase I footprint
analysis (13) using the fragment 11(t) subfragment of frag-
ment II. Fragment 11(t) was labeled on both the coding and
noncoding strands in separate experiments. DNA-protein
complexes were formed and subjected to DNase I digestion.
Radiolabeled bands representing free and complexed DNA
were cut from the gel, eluted, and run in parallel on dena-
turing polyacrylamide gels. One distinct region of altered
FIG. 5. Competition and cross-competition experiments. LPS-
induced nuclear extracts were incubated with radiolabeled fragment
I (lanes 2 through 5 and 10 through 13) and fragment II (lanes 7
through 9 and 14 through 17). Lanes 1 and 6 contain unstimulated
nuclear extract. Lanes 2, 7, 10, and 14 contain LPS-stimulated
extract without competitor. Competitor fragments are I(t) (lanes 3,
11, and 15), 1.9-kb upstream fragment (lane 4), dimerized Pstl
fragment from fragment IV (lanes 5 and 9), fragment 11(t) (lanes 8,
12, and 16), Aa X box plus flanking sequence (44 bp) (lane 13), and
randomly scrambled sequence of 27 bp from DRa X box (X' box)
(lane 17). All competitor fragments were added in molar excess at 50
ng.
reactivity was consistently identified in fragment 11(t) be-
tween free and protein-bound DNA in separate experiments
(Fig. 6A). Binding of the LPS-induced protein to the non-
coding strand produced three distinct hypersensitive sites.
In the complementary region of the coding strand, binding of
the LPS-induced protein led to a modest decrease in reac-
tivity in the central portion of this complementary region.
This decrease was seen reproducibly in three separate
experiments. We have designated this region the LPS-
responsive element (LRE). Additional attempts to obtain
footprints by using the nuclease activity of 1,10-phenanthro-
line-copper ion (19) revealed no altered reactivity of bases in
bound compared with free DNA (results not shown). Of
interest is that in two of the three experiments with DNase I
digestion, modest protection was also seen on the coding
strand in the previously described B-cell-responsive element
(BRE-2) (Fig. 6). This region, BRE-2 (5), represents a target
sequence of a previously described IL-4-inducible DNA-
binding protein, active at low levels in nuclear extracts from
untreated spleen cells. The relative locations of the binding
sites of the LPS-inducible and IL-4-inducible DNA-binding
proteins are shown in Fig. 6B.
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FIG. 6. (A) DNase I footprint of coding and noncoding strands.
Free and bound bands generated from DNA-binding gel assays were
purified on nondenaturing polyacrylamide gels after digestion with
DNase Maxam-Gilbert sequence reactions were performed on
labeled probe DNA, and the products were coelectrophoresed.
Lanes 1 and 2, DNA from the coding strand; lanes 3 and 4. DNA
from the noncoding strand. F and B. Cleavage products of unbound
(F) and complexed (B) DNA. H, Areas of hypersensitivity; P. areas
of protection. Hypersensitive sites span the LRE (bases 18 to 71. as
numbered in Fig. 3). The lower P falls in the LRE sequence (bases
18 to 71), while the upper P falls in BRE-2 (5). (B) Schematic
representation of the upstream region of Aa. Hinfl sites are marked
with verticle hatches. Solid boxes labeled X and Y identify con-
served X and Y box consensus sequences within fragment IV. Open
box in fragment I identifies the previously defined BRE-1. Open box
in fragment lI identifies the previously defined BRE-2. with se-
quence shown above. Cross-hatched box shows newly defined
LRE, with sequence shown above.
To confirm that the region identified as the LRE was in
fact the site of protein binding, a 53-bp oligonucleotide
corresponding to this region was synthesized (Fig. 6B) and
used in competition experiments (Fig. 7). Protein binding
(Fig. 7, lane 1) was partially prevented by 25 ng of oligonu-
cleotide (lane 2) and was completely prevented by 50 ng
(lane 3) and 100 ng (lane 4). Two distinct unrelated compet-
itor oligonucleotides of similar lengths did not prevent bind-
ing at 100 ng (Fig. 7, lane 5) and 50 ng (data not shown) in
four parallel experiments. One competitor contained ran-
domly scrambled sequence from the X box of DRQ(X' box),
whereas the second contained sequence from the X box of
the DQ3 gene. The 53-bp LRE oligonucleotide was also able
to prevent binding to radiolabeled fragment I, giving further
_eitor) - Xx
1 2 4 5
FIG. 7. Competition experiments with LRE. LPS-induced nu-
clear extracts were incubated with radiolabeled fragment II without
(lane 1) and with (lanes 2 through 5) competitor. Lanes 2 through 4,
Preincubation with the 53-bp LRE oligonucleotide spanning the
protected region at 25, 50, and 100 ng, respectively; lane 5, prein-
cubation with an unrelated oligonucleotide, X' box, containing
randomly scrambled sequence from the X box of DRa at 100 ng.
evidence that the same protein is binding to both fragments.
Therefore, we conclude that the protected region, LRE,
identified by DNase I footprinting, is a target site of specific
binding by the LPS-inducible DNA-binding protein. The
previously identified NF-KB-like target sequence is present
within this LRE.
The LPS-inducible DNA-binding protein is distinct from
NF-KB. The presence of the NF-KB-like sequence within the
target binding site of this LPS-inducible protein was consis-
tent with the possibility that this protein may be NF-KB. To
test this possibility, a 53-bp oligonucleotide containing the
true NF-KB site flanked by the K enhancer sequences iden-
tified by Picard and Schaffner (29) was synthesized and used
in competition experiments (Fig. 8B). The immunoglobulin
NF-KB target sequence at 25, 50, and 100 ng (Fig. 8B, lanes
3 through 5, respectively) was unable to prevent binding to
fragment II probe, compared with a control reaction without
competitor DNA (lane 2). To further demonstrate that the
LPS-inducible Au DNA-binding protein was not NF-KB, an
additional 53-bp oligonucleotide was prepared from the LRE
target sequence in the Ak upstream region. This oligonucle-
otide contained mutations in the three key G residues (Fig.
8A), identified by Sen and Baltimore (37), which are required
for binding by NF-KB (2, 39). Despite these mutations, this
oligonucleotide prevented binding to fragment II at 25, 50,
and 100 ng (Fig. 8B, lanes 6 through 8, respectively). Control
oligonucleotides did not inhibit complex formation (Fig. 8B,
lanes 10 and 11), whereas the LRE oligonucleotide did so
(lane 9). Identical results were obtained when competition
experiments were performed with radiolabeled fragment I
(data not shown). Therefore, we conclude that this LPS-
inducible DNA-binding activity is not NF-KB.
DISCUSSION
Cells of the B lineage progress through known develop-
ment stages, from bone-marrow-derived stem cells, to pre-B
cells, to mature B cells able to secrete immunoglobulin, and
finally to plasma cells. The expression of Ia in B cells is
determined both by the B-cell developmental stage and by
certain external stimuli. Treatment of pre-B cells with LPS is
known to induce their differentiation into immunoglobulin-
secreting B cells (24). Previous data from our laboratory
have suggested that class II (Ia) antigen and immunoglobulin
gene expression may be controlled by distinct pathways in
early B cells (30). We therefore undertook to study the
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FIG. 8. Binding competition assay with NF-KB target sequence
and oligonucleotides. (A) Oligonucleotide sequences used in com-
petition assays. Note that the mutant LRE oligonucleotide has
mutations in three key G residues. (B) Lane 1, Radiolabeled
fragment II probe alone; lanes 2 through 11, LPS-induced nuclear
extracts without (lane 2) and with (lanes 3 through 11) competitor.
Lanes 3 through 5, True NF-KB target sequence at 25, 50, and 100
ng, respectively; lanes 6 through 8, mutant oligonucleotide spanning
the LRE; lane 9, true LRE; lane 10, 27-bp oligonucleotide compris-
ing the randomly scrambled sequence from the X box of DRa (X'
box); lane 11, a second unrelated oligonucleotide spanning the DQI
X box.
effects of LPS on expression of class II (Ta) antigen in cells
of the B lineage.
The final effect of LPS-treatment of B cells on the surface
expression of Ia antigens is undoubtedly complex. Several
investigators have shown an increase in surface Ia expres-
sion after treatment with LPS. This effect appears to be cell
cycle dependent and is probably most pronounced at 36 to 48
h (23), although some investigators have seen this effect as
late as 64 to 84 h (41). In a purified B-cell population, Dennis
et al. (9) have demonstrated an approximately twofold
increase in surface Ta after treatment with LPS as early as 9
h. However, the increase in cell size and thus in cell surface
area was not accounted for, raising the possibility that the
number of Ta molecules per unit surface area was not
increased at this early time point. The FACS data obtained
in our laboratory demonstrate no substantial increase in
surface Ia expression at 18 h. No increase in surface Ia
expression was seen in two of seven experiments in splenic
preparations from athymic mice, and only a modest increase
was seen in five of seven experiments at 18 h. Furthermore,
if the increase in surface area of LPS blasts is accounted for,
there may be no significant change in the density of surface
la antigen expression in whole spleens from athymic mice
after 18 h of LPS stimulation. In contrast, IL-4 treatment of
athymic mouse spleen preparations led to a significant in-
crease in surface Ia expression in our hands (data not
shown).
It is possible that some of this discrepancy is due to the
difference in examining a purified B-cell population as op-
posed to a preparation of whole spleen as in our studies,
although spleen cells from athymic mice are predominantly
B cells. However, when steady-state mRNA levels for Aa
were examined in these splenic preparations from athymic
mice, a significant decrease in mRNA levels was seen by 4 h
and was stable until at least 18 h. The level of mRNA for
A50, a housekeeping gene, did not change with LPS treat-
ment, arguing that the decrease in Aot mRNA is not an
artifact of an increase in total mRNA. This had been
previously demonstrated by dot blot analysis when mRNA
levels for Au and AP were examined in BALB/c spleen cells
treated with LPS (33). In that study, a significant decrease in
class II mRNA levels occurred by 5 h, and levels remained
low at the last time point examined, 12 h. These data lead us
to conclude that LPS may be a negative regulator of Ta
expression in B cells at these early time points.
The regulation of class II gene steady-state mRNA in
response to multiple stimuli has been shown to be controlled
at the level of gene transcription (27, 32). Such transcrip-
tional control is mediated by cis-acting DNA sequences and
by transcription factors that bind to these sequences. In the
instance of immunoglobulin K-chain expression, some of
these regulatory elements have been identified. In the pre-B
cell line 70Z/3 the activation of transcription of the K-chain
gene by LPS is known to be mediated in part by the protein
NF-KB, which binds to a transcriptional motif within the
K-chain enhancer (37). The DNA-binding activity of NF-KB
is inducible by treatment with LPS (38). Sequence analysis
of the 1.23 kb upstream of the Aot gene revealed the presence
of an NF-KB-like binding site. Although an NF-KB-like
binding sequence is present in the upstream region of the Ea
gene, the Ea. and immunoglobulin genes appear to rely on
different factors to achieve B-cell-specific expression (12).
We therefore chose to examine unstimulated and LPS-
stimulated nuclear extracts from spleen preparations from
athymic mice, which consist predominantly of B cells, in
order to identify a nuclear factor analogous or identical to
NF-KB which may bind to the upstream regulatory region of
a class II (Ia) gene, Aox.
In the present report we demonstrate the presence of an
LPS-inducible DNA-binding protein in nuclear extracts pre-
pared from splenic preparations from athymic mice. This
LPS-inducible protein binds to two fragments prepared from
the upstream regulatory region of A",k, and these fragments
cross-compete for binding. By using DNase I footprint
analysis, a target binding sequence was identified in frag-
ment II of the Hinfl digest of the upstream regulatory region
of A k. An oligonucleotide synthesized from this LRE
successfully competes for binding to fragment II. Located
within the target binding site of the LPS-inducible protein is
a nucleotide sequence with a 10/12 homology to the binding
site of the known LPS-inducible B-cell protein, NF-KB.
Recent studies on transcription factors provide evidence that
a factor which serves as an activator of gene expression can
function as a repressor of gene expression when bound to a
somewhat different target sequence (16). This raised the
possibility that the LPS-inducible protein binding to be
upstream region of Aot might be NF-KB even though NF-KB
acts as a positive regulator in pre-B cells. However, an
oligonucleotide containing the true NF-KB binding site was
unable to compete for binding. In addition, three G residues
which are essential for the binding of NF-KB have been
identified (37). When the three G residues present in our
NF-KB-like sequence were mutated from GGG to AAT, the
mutated oligonucleotide was still able to prevent binding,
suggesting that these G residues are not essential for the
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binding of this protein. These data strongly suggest that this
LPS-inducible protein is distinct from NF-KB. Therefore,
LPS leads to the induction of two distinct DNA-binding
proteins in cells of the B lineage, one binding to a site in the
K-chain enhancer, NF-KB, and acting as a positive regulator,
and one binding upstream of an Ia gene, which we postulate
may be a negative regulator. This provides further evidence
for the hypothesis that B-cell expression of class II and
immunoglobulin genes proceeds along distinct pathways.
Taken together, these data demonstrate that the LPS-
inducible DNA-binding protein is distinct from NF-KB and
binds to Aa upstream gene sequences. They further suggest
that this LPS-inducible protein may be a factor in mediating
the negative regulation of Aa gene expression. Several
examples of both cis-acting DNA elements and trans-acting
factors which can repress gene transcription have already
been described (35). An example of a cis-acting DNA
element that exerts a negative regulatory effect on gene
transcription is the DNA element in the upstream region of
the HMG coenzyme A reductase gene, in which positive and
negative regulatory elements are closely associated (28). The
large T antigen of simian virus 40 is a trans-acting repressor
which regulates the synthesis of virus-coded proteins by
decreasing the rate of early-strand RNA synthesis (40). In
addition, proteins which displace or prevent the binding of
positive trans-acting factors have recently been elucidated.
For example, a CCAAT displacement protein which is
present only in nuclear extracts from embryos in which the
sperm H2B gene is inactive has been described. This protein
binds to sequences overlapping the proximal CCAAT ele-
ment of the sperm H2B promoter and thus prevents the
binding of the CCAAT-binding factor (3). Glucocorticoids
have long been known to inhibit the transcription of several
genes, including collagen and stromelysin (1, 42). It has now
been demonstrated that the same glucocorticoid receptor
known to activate gene expression can lead to negative
regulation by interfering with the binding or activity of
positively acting factors (1).
We have currently identified two target sequences for
B-cell nuclear proteins within fragment II of a Hinfl digest of
the 1.9-kb upstream regulatory region of the A k gene. The
LPS-inducible DNA-binding protein binds preferentially to
one of these regions, designated LRE. The previously de-
scribed IL-4-inducible DNA-binding protein binds to a sec-
ond sequence called BRE-2 (5). These target sequences are
separated by only 20 bp (Fig. 6B). We have preliminary data
(E. Gravallese and L. Glimcher, unpublished results) dem-
onstrating that the LRE sequence is able to prevent binding
of the IL-4-induced binding protein to fragment II, and
conversely, that BRE-2 is able to prevent binding of the
LPS-induced protein to fragment II. In addition, in two
experiments the region of DNase I protection delineated by
the LPS-induced nuclear extract showed modest protection
of the BRE-2 target site. This may represent constitutive
binding of the IL-4-induced protein, which is present at
baseline in unstimulated nuclear extracts (5). Alternatively,
it may demonstrate the ability of the LPS-induced DNA-
binding protein to bind to either the LRE or the BRE-2 site.
One possible model for Aot gene regulation would be that
two inducible DNA-binding proteins result from treatment
with either LPS or IL-4 and that each protein is able to bind
to either the LRE or the BRE-2 site. The LPS-inducible
DNA-binding protein binds preferentially to the LRE se-
quence, as indicated by its characteristic pattern of DNase I
protection and hypersensitivity. It is possible that protein
binding to this sequence prevents the binding of positive
regulatory elements such as the IL-4-inducible protein. The
LPS-inducible DNA-binding protein could thus act as a
negative regulator of Aa gene expression. An alternative
hypothesis is that a single protein is affected by both stimuli
and binds preferentially to the LRE sequence only when
affected by LPS. The target choice as well as the transcrip-
tional effect would then depend upon the original external
stimulus. Further studies are in progress to explore these
possibilities.
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